In AML with chromosome 16 inversion, CBFβ-SMMHC hinders the activity of RUNX1, the primary transcription factor in the hematological system, and interferes with the suppression of MYC expression, which is regulated by RUNX1 [26, 27]. Here, RUNX1 is linked to acute myeloid leukemia.